N2004-04: Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium
New Approaches to Neuroblastoma Therapy Consortium
Mayo Clinic
Eastern Cooperative Oncology Group
Radiation Therapy Oncology Group
Case Comprehensive Cancer Center
University of California, San Francisco
Celgene
University of California, San Francisco
M.D. Anderson Cancer Center
Montefiore Medical Center
University of Washington
AbbVie
GlaxoSmithKline
Takeda
University of California, Davis
Alliance for Clinical Trials in Oncology
Memorial Sloan Kettering Cancer Center
Janssen Research & Development, LLC
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
Seagen Inc.
University of Chicago
National University Hospital, Singapore
Eisai Inc.
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Memorial Sloan Kettering Cancer Center
National University Hospital, Singapore
M.D. Anderson Cancer Center
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Abbott
Abbott